Word

MYPHALOR

Status

Pending

Status Code

730

Status Date

Tuesday, November 21, 2023

Serial Number

97441094

Mark Type

4000

Filing Date

Thursday, June 2, 2022

Published for Opposition

Tuesday, April 4, 2023

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications

MY PHALOR

Trademark Events

Nov 23, 2023

Notice Of Approval Of Extension Request E-Mailed

Nov 21, 2023

Sou Extension 1 Granted

Nov 21, 2023

Sou Extension 1 Filed

Nov 21, 2023

Sou Teas Extension Received

May 30, 2023

Noa E-Mailed - Sou Required From Applicant

Apr 4, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 4, 2023

Published For Opposition

Mar 15, 2023

Notification Of Notice Of Publication E-Mailed

Mar 2, 2023

Approved For Pub - Principal Register

Feb 28, 2023

Assigned To Examiner

Jun 13, 2022

New Application Office Supplied Data Entered

Jun 6, 2022

New Application Entered